ICBio Clinical Research

ICBio operates as a Contract Research Organization situated in Bangalore, India, specializing in the execution of Bioequivalence / Bioavailability studies ( BA/ BE studies), Pharmacokinetic / Pharmacodynamic studies, Clinical End Point studies, and clinical safety and efficacy studies for Pharma, Biotech, Nutraeuticals, Herbals, Cosmetics and OTC Product companies while strictly following 21 CFR ICH GCP regulatory compliant systems and procedures. The facility is sanctioned by Drug Controller General of India (DCGI), CDSCO, ISO 9001:2015, ISO 15189:2012 / NABL Accredited Clinical Laboratory, Inspected and approved by Ministry of Health-Kazakhstan and other relevant regulatory authority requirements. BE studies have been conducted for US FDA, DCGI, FDA Philippines, MoH Khazakhstan, Tanzania, Vietnam, Ukraine and numerous ROW country regulatories with no observations to date. The BA/BE facility is equipped with cutting-edge amenities such as a Clinical pharmacology unit with ICU Beds for conducting BA/BE studies with Access controlled areas like Clinical Units / CPU, Bio analytical Laboratory, Volunteer screening, Volunteer Information centres, Central Laboratory Archives and Pharmacy. ICBio is renowned as a prominent full services CRO in Asia, located in Bangalore, India, specializing in the execution of Clinical Development and BA / BE studies Services for the Pharmaceuticals, Biotech, Nutraceuticals and Cosmetics Industries. The organization possesses extensive expertise in clinical trial and project management, having managed intricate clinical development programs of biologics, small molecules, and completing them within the time and cost constraints as defined by the clients. Sponsors' interests are accommodated in sync with timelines and milestones.